In addition to genetic event, our data indicate that DAB2IP, a novel family of RasGTPase-activating protein family as a potent tumor suppressor, is epigenetically silenced [3, 4], which is suppressed by EZH2 and other epigenetic machinery such as DNA methylation and histone acetylation [5-7]. The gene discussed is DAB2IP; the disease is neoplasm.